Search

Your search keyword '"Amato, M."' showing total 130 results

Search Constraints

Start Over You searched for: Author "Amato, M." Remove constraint Author: "Amato, M." Topic medicine.disease Remove constraint Topic: medicine.disease
130 results on '"Amato, M."'

Search Results

1. As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations

2. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

3. The prevalence of sleep impairments and predictors of sleep quality among patients with asthma

4. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

5. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

6. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

7. Italian consensus on treatment of spasticity in multiple sclerosis

8. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome : a Randomized Clinical Trial

9. Characteristics and treatment regimens across ERS SHARP severe asthma registries

10. Lung Recruitment in Obese Patients with Acute Respiratory Distress Syndrome

11. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event

12. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry

13. Aggressive multiple sclerosis (2): Treatment

14. Aggressive multiple sclerosis (1) : Towards a definition of the phenotype

15. Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

16. Association of celiac disease in patients with multiple sclerosis in Tuscany

17. Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study

18. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI

19. HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

20. Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

21. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

22. Allergenic Pollen and Pollen Allergy in Europe

23. Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

24. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

25. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes:a genetic association study

26. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study

27. Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

28. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

29. Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

30. Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis - Results of the βPlus observational cohort study

31. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis

32. Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience

33. The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis

34. Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results

35. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study

36. The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy

37. Rate of pregnancy-related relapse in multiple sclerosis

38. Spondylolysis of the lumbar spine: demonstration of defects and laminal fragmentation

39. Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage

40. The social cost of chronic kidney disease in Italy

41. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

42. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis

43. Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression

44. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

45. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

46. No phenotypic differences for polycystic ovary syndrome (PCOS) between women with and without type 1 diabetes mellitus

47. Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease

48. Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler

49. Two-dimensional versus three-dimensional Frӓnkel Manoeuvre: a reproducibility study

50. Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

Catalog

Books, media, physical & digital resources